COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,196 Articles (22,713 medRxiv, 8,483 bioRxiv)

Most recent first Previous |  Page 1016: Articles 10151-10160  | Next

Rapid turnaround multiplex sequencing of SARS-CoV-2: comparing tiling amplicon protocol performance
Constantinides, B., Webster, H., Gentry, J., Bastable, J., Dunn, L., Oakley, S., Swann, J., Sanderson, N. D., Fowler, P. W., Ma, G., Rodger, G., Barrett, L., Jeffery, K. J., Peto, T. E. J., Stoesser, N., Street, T. L., Crook, D. W.
10.1101/2021.12.28.21268461 — Posted: 2022-01-01
Severity of COVID-19 reinfection and associated risk factors: findings of a cross-sectional study in Bangladesh
Islam, M. Z., Riaz, B. K., Ashrafi, S. A. A., Farjana, S., Efa, S. S., Khan, M. A.
10.1101/2021.12.26.21268408 — Posted: 2022-01-01
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
Miyamoto, S., Arashiro, T., Adachi, Y., Moriyama, S., Kinoshita, H., Kanno, T., Saito, S., Katano, H., Iida, S., Ainai, A., Kotaki, R., Yamada, S., Kuroda, Y., Yamamoto, T., Ishijima, K., Park, E.-S., Inoue, Y., Kaku, Y., Tobiume, M., Iwata-Yoshikawa, N., Shiwa-Sudo, N., Tokunaga, K., Ozono, S., Hemmi, T., Ueno, A., Kishida, N., Watanabe, S., Nojima, K., Seki, Y., Mizukami, T., Hasegawa, H., Ebihara, H., Maeda, K., Fukushi, S., Takahashi, Y., Suzuki, T.
10.1101/2021.12.28.21268481 — Posted: 2022-01-01 Discussion: Onsite
Performance of COVIDSeq and Swift normalase amplicon SARS-CoV-2 panels for SARS-CoV-2 Genomes Sequencing: Practical Guide and Combining FASTQ Strategy
Choi, H., Hwang, M., Navarathna, D., Xu, J., Lukey, J., Jinadatha, C.
10.1101/2021.12.30.21268553 — Posted: 2022-01-01
Magnitude and breadth of neutralizing antibody responses elicited by SARS-CoV-2 infection or vaccination
Sievers, B. L., Chakraborty, S., Xue, Y., Gelbart, T., Gonzalez, J. C., Cassidy, A. G., Golan, Y., Prahl, M., Gaw, S. L., Arunachalam, P. S., Blish, C. A., Boyd, S. D., Davis, M. M., Jagannathan, P., Nadeau, K. C., Pulendran, B., Singh, U., Scheuermann, R. H., Frieman, M. H., Vashee, S., Wang, T. T., Tan, G. S.
10.1101/2021.12.30.21268540 — Posted: 2022-01-01
COVID-19 severity prediction based on patient risk factors and number of vaccines received
Israel, A., Schäffer, A. A., Merzon, E., Green, I., Magen, E., Golan-Cohen, A., Vinker, S., Ruppin, E.
10.1101/2021.12.31.21268575 — Posted: 2022-01-01
Head-to-head comparison of nasal and nasopharyngeal sampling using SARS-CoV-2 rapid antigen testing in Lesotho
Labhardt, N. D., Gonzalez Fernandez, L., Katende, B., Muhairwe, J., Bresser, M., Amstutz, A., Glass, T. R., Ruhwald, M., Sacks, J. A., Escadafal, C., Mareka, M., Mookho, M. S., de Vos, M. D., Reither, K.
10.1101/2021.12.29.21268505 — Posted: 2022-01-01
Social isolation and psychological distress among southern US college students in the era of COVID-19
Giovenco, D., Shook-Sa, B. E., Hutson, B., Buchanan, L., Fisher, E. B., Pettifor, A.
10.1101/2021.12.31.21268596 — Posted: 2022-01-01
From Delta to Omicron: analysing the SARS-CoV-2 epidemic in France using variant-specific screening tests (September 1 to December 18, 2021)
Sofonea, M. T., Roquebert, B., Foulongne, V., Verdurme, L., Trombert-Paolantoni, S., Roussel, M., Haim-Boukobza, S., Alizon, S.
10.1101/2021.12.31.21268583 — Posted: 2022-01-01
Protective effect of BNT162b2 vaccination on aerobic capacity following mild to moderate SARS-CoV-2 infection: a cross sectional study, Israel, March-December 2021
Blumberg, Y., Edelstein, M., Abu Jabal, K., Golan, R., Perets, Y., Saad, M., Levinas, T., Dabbah, S., Israeli, Z., Yacoubi, S., Abu Raya, A., Amital, A., Halabi, M.
10.1101/2021.12.30.21268538 — Posted: 2022-01-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).